01-04-2024 | Headache | Case report
Dexamfetamine
Rebound effect in the form of headaches following off-label therapy (in unapproved indication) with dexamfetamine
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event